Global Market for PCR in Point-of-Care Diagnostics Projected to Reach $2.1 Billion by 2029
June 05, 2024 07:07 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics 2024-2029" report has been added to ResearchAndMarkets.com's offering. The...
Fortuna Announces Offering of Convertible Senior Notes
June 05, 2024 07:05 ET
|
Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (TSX: FVI) (NYSE: FSM) (“Fortuna” or the “Company”) announces that it is offering convertible senior notes...
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
June 05, 2024 07:05 ET
|
Y-mAbs Therapeutics, Inc.
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and...
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
June 05, 2024 07:05 ET
|
Eldorado Gold Corporation
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or “the Company”) is pleased to announce that all director nominees, as listed in the Management...
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024
June 05, 2024 07:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...
SummerSeries in Trillium Park Returns at Ontario Place
June 05, 2024 07:01 ET
|
Ontario Place
Toronto, ON, June 05, 2024 (GLOBE NEWSWIRE) -- SummerSeries returns to Trillium Park at Ontario Place this summer with another season of free, family-friendly programming from July 13 to September...
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024 07:00 ET
|
SpringWorks Therapeutics, Inc.
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2024 07:00 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AutoZone Vendor Summit Recognizes Contributions of Top Suppliers
June 05, 2024 07:00 ET
|
AutoZone, Inc.
MEMPHIS, Tenn., June 05, 2024 (GLOBE NEWSWIRE) -- AutoZone (NYSE: AZO) recognized 17 of its top suppliers at their annual Vendor Summit. The awards honor companies that provided exceptional...
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
June 05, 2024 07:00 ET
|
LSL Pharma Group Inc.
Up to $3.0 M in cash proceedsUp to $1.5 M in debts conversion BOUCHERVILLE, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a...
- June 05, 2024 07:07 ET Global Market for PCR in Point-of-Care Diagnostics Projected to Reach $2.1 Billion by 2029
- June 05, 2024 07:00 ET GXO Releases 2023 ESG Impact Report